Trial Profile

A Phase IIa Multicenter Trial to Assess the Efficacy, and Safety of Anakinra in Patients With Intravenous Immunoglobulin-resistant Kawasaki Disease

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 28 Oct 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Anakinra (Primary)
Indications Mucocutaneous lymph node syndrome
Focus Proof of concept; Therapeutic Use
Acronyms KAWAKINRA

Most Recent Events

11 Aug 2020 Results published in the Arthritis and Rheumatology
01 Jul 2019 Status changed from active, no longer recruiting to completed.
15 Jun 2019 Status changed to active, no longer recruiting as per results presented at the 20th Annual Congress of the European League Against Rheumatism

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com